Pros and Cons of COVID-19 Vaccines.
DOI:
https://doi.org/10.14738/bjhmr.101.14020Keywords:
COVID-19, vaccines, VAERS, MTHFR, SARSAbstract
We are faced with a typical flu of the winter season, identical to many others we have known in the past. The only difference is that it is not a flu virus, but COVID, but this does not justify the media terror that has spread. On the other hand it is now established that for certain types of influences from covid it is enough to resort to oral antiviral therapies.
The variant that is circulating today is the same that circulated in Africa when it was summer here, without serious consequences. The Africans themselves denied Western alarmism, saying that what was happening exaggerated in portraying the South African variant as dangerous. The efficacy of vaccines against the COVID-19 subsided after the delta variant became predominant. The efficacy of the vaccines above 65 years of age with messenger RNA has remained high in the sense of their protection against the hospitalization. New variants seem to avoid the immune response and show signs of spreading more rapidly. Some data seem to indicate that the new omicron variant may be milder, but all the same will lead to one plethora of hospital admissions.
Betacoronavirus infection induces strong and long-lasting immunity of T lymphocytes to proteins structural and CD4 and CD8 T cells were recognized in all convalescents who recognized multiple regions of nucleocapsid protein (NP).
The unvaccinated person runs no risk if he maintains a normal hygiene profile. The vaccinated with RNA messenger vaccines can be a vehicle of contagion as long as he produces the first antibodies since it could be already infected with any of the 4 benign human coronaviruses and therefore replicate the vaccine received before to produce the specific antibodies that will allow him to be immune to Covid-19 until the duration of at least twelve months from the first administration. In the case of vaccination with adenovirus vaccine as a vector and the spike protein carrier gene, no danger for the unvaccinated cohabitant.
Since young people have their own immunological response towards this epidemic from COVID-19, it is enough not to create the storm of interleukins of adults and the elderly, in regards by the same agent.
Therefore their vaccination is almost useless also because recent American studies report the possibility of myocarditis and other damages.
References
Tarro G. Environment and Virus Interactions: Towards a Systematic Therapy of SARS-CoV-2. British Journal of Healthcare and Medical Research, 9(4). 253-260. August 25, 2022
Doshi P. 2021. Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data. https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-needmore-details-and-the-raw-data/
Mc Gonagle Dennis G. Health-care workers recovered from natural SARS-Cov-2 infection should be exempt frommandatory vaccination edicts. The Lancet vol 4, march 2022. Doi: 10-1016/S2665-9913(22)00038-8.
Lavine JS, Bjornstad ON and Anita R. 2021. Immunological characteristics govern the transition of COVID-19 to endemicity. Science, Vol. 371, Issue 6530, pp. 741-745, DOI: 10.1126/science.abe6522.
Tarro G. The Italian COVID-19 epidemic and the global pandemic. Prevention and therapies. International Journal of Current Research. Vol. 13, Issue, 05, pp.17261-17266, May, 2021. DOI: https://doi.org/10.24941/ijcr.41347.05.2021.
Tarro G. L’epidemia italiana e la pandemia globale. ND Natura Docet, Anno II n. 6 Giugno 2021, pp 12-19.
Zhang R, Huo C, Wang X. Two Common MTHFR Gene Polymorphisms (C677T and A1298C) and Fetal Congenital Heart Disease Risk: An Updated Meta-Analysis with Trial Sequential Analysis. Cell Physiol Biochem 2018 Mar 15; 45(6): 2483-2496. Doi: 10.1159/000488267.
El-baz F,1 Abd El-Aal M, Kamal TM et al. Study of the C677T and 1298AC polymorphic genotypes of MTHFR Gene in autism spectrum disorder. Electron Physican. 2017 Sep. 25; 9(9): 5287-5293. Doi: 10.19082/5287
Saadatnia M, Salehi M, Movahedian A et al. Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reducates in cerabral venous and sinus thrombosis: A case-control study. J Res Med Sci. 2015 June; 20(6): 554-562. DOI: 10.4103/1735-1995.165956
Giannakou K, Evangelou E and Papatheodorou SI. Genetic and non-genetic risk factors for pre-eclampsia umbrella review of systematic review and meta-analyses of observational studies. Ultrasound Obstet Gynecol. 2017 Nov 16. https://doi.org/10.1002/uog.18959.
Fekih-Mrissa N, Mansour M, Sayeh A. The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer’s Disease. Am J Alzheimers Dis Other Demen. 2017 Sep; 32(6): 342-346. Doi: 10.1177/1533317517705223.
Tarro G. On the End of a Nightmare (COVID-19). The Role of the Immune System. British Journal of Healthcare and Medical Research – vol 9, (6) 194-197, December 25,2022.
Malone R.W. Lies my gov’t told me and the better future coming. Preface Kennedy R.F. Children’s Health Defense, February 2023.
Mart M. Lamers & Bart L. Haagmans. SARS-CoV-2 pathogenesis Nature Reviews Microbiology volume 20, 270–284, 2022.
Liu J, Wang J, Xu J et al. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discovery 7:99,2021.
Zhang L, Alexsia R, Khalil A et al 2020. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome. BioRXiv.
Mina JM, Peto TE, Finana MG et al. Clarifying the evidence on SARS-Cov2 antigen rapid tests in public health response to COVID-19. The Lancet vol 397, issue 10283, February 17, 2021 DOI:https://doi.org/10.1016/S0140-6736(21)00425-6.
Arantes de Araújo L, Veloso CF, de Campos Souza M, Coelho de Azevedo JM and Tarro G. 2020. The potential impact of the COVID-19 pandemic on child growth and development: a systematic review. Running title: COVID-19 pandemic and child growth and development. Journal de Pediatria, DOI: 10.1016/ipd.2020.08.008.
Tarro G. COVID-19. The end of a nightmare. www.edizionihelicon.it July 2022 Fano (PU), Italy
Pulliam JRC, Van Schalkwyk C, Govender N et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. SCIENCE Vol 376, Issue 6593 - 15 Mar 2022. DOI: 10.1126/science.abn4947.
Le Bert N, T Tan A, Kunasegaran K et al. 2020. Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals. bioRxiv doi: https://doi.org/10. 1101/2020.05.26. 115832.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Giulio Tarro

This work is licensed under a Creative Commons Attribution 4.0 International License.